Collaborators
Co-Investigators on Our NIH Funded Projects:
Dr. Cory Brayton is the Director of The Phenotyping Core at Johns Hopkins. Dr. Brayton’s primary research interest is in collaborating as a pathologist in phenotyping and other translational research initiatives. Dr. Brayton’s expertise includes the spontaneous pathology and genetics of research mice, as well as the impact of infectious and other environmental factors on pathology. She has published on comparative cardiovascular, pulmonary, renal, musculoskeletal, hematopoietic, neural and ophthalmic pathology, comparative carcinogenesis, autoimmune diseases and infectious diseases, in mice and other species. She is a valuable member of our team and serves as a co-investigator on our NIH funded project.
Dr. Edward Ratovitski is a faculty member of the Dermatology department at Johns Hopkins with joint appointments in Pathology, Medicine, Otolaryngology-Head and Neck Surgery and is a Member, Graduate Program in Biochemistry, Cellular and Molecular Biology. His research focuses on signal transduction mechanisms involved in regulation of NOS2 and p63 during embryonic development, tumorigenesis and inflammation. Edward is a co-investigator on our NIH funded grant, helping us to understand the interactions of normal βA3/A1-crystallin with other proteins in astrocytes using yeast two-hybrid expression technology.
Dr. Gerard A. Lutty is the G. Edward and G. Britton Durell Professor of Ophthalmology. His laboratory studies the development of blood vessels in the eye and how they change in diseases like age-related macular degeneration, retinopathy of prematurity, sickle cell and diabetic retinopathies. Our quest to understand the role of glial cells in ocular vascular development and disease is only possible because of his support; he is co-investigator on two of our NIH funded R01 grants.
Consultants on Our NIH Funded Projects:
Dr. Ahmet Hoke is the Director of the Daniel B. Drachman Division of Neuromuscular Diseases at Johns Hopkins and focuses on neuromuscular diseases with a particular interest in those affecting the peripheral nervous system. Dr. Hoke is actively involved in, and provides intellectual support for, our frogleg spontaneous mutant rat project. He serves as a consultant to our NIH funded grant.
Dr. Nicholas Maragakis is a faculty member in Neurology at Johns Hopkins, treating patients with a variety of neuromuscular disorders. Dr. Maragakis has interests in both the basic science of neurologic disease as well as in clinical investigations for treating neurologic disorders. We feel very fortunate to have Nick as a collaborator who helps us with the neurometric studies on the frogleg spontaneous mutant rat project and is a consultant in our NIH funded grant.
Dr. Eric Wawrousek is the Chief of The Transgenics and Genome Manipulation Section at the National Eye Institute, NIH. Dr. Wawrousek provides invaluable support to our laboratory by providing his expertise in designing transgenic constructs and generating transgenic mouse lines and in the also creation of our conditional knockout mouse. He is a consultant in our NIH funded projects.
Dr. Morton F. Goldberg, the Joseph E. Green Professor in Macular Degeneration and other Retinal Diseases, directed the Wilmer Eye Institute from 1989 to 2003. He is also a member of the Institute of Medicine of the National Academy of Sciences and is a consultant in our NIH funded grant to study Persistent Fetal Vasculature (PFV). Dr. Goldberg is a world authority on PFV disease.
Dr. Donald J. Zack, the Guerrieri Family Professor of Ophthalmology in the Center for Genetic Engineering and Molecular Ophthalmology at the Wilmer Eye Institute, is a glaucoma specialist and molecular biologist whose research focuses on molecular approaches to the study of retinal development, function, and disease. Don is very supportive of our research endeavors and is a consultant in our NIH funded project to study the interactions between ganglion cells and astrocytes during retinal development.
